B.Riley/FBR Reiterates Buy Rating on Novavax (NVAX)

January 21, 2020 12:57 PM EST Send to a Friend
B.Riley/FBR analyst Chad Mabry reiterated a Buy rating and $12.00 price target ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login